Date
The Issue: Due to the shortage of medroxyprogesterone acetate 150 mg/mL injectable suspension (vials) in Canada, Health Canada has approved the importation of US-labelled pre-filled syringes from Pfizer in order to prevent supply gaps until Canadian product is available again (likely mid 2022).
Clinical Use: Medroxyprogesterone acetate injectable suspension is mainly used as a contraceptive.